This is a minor procedural win for BSX in one of many pelvic mesh cases. It does not change the overall litigation landscape. Monitor for any class action or MDL developments, but this individual case is immaterial to BSX's financials.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 1 $48.08entry
- T+1 · 3mo ago +0.60%α +0.16% · $48.37
- T+5 · 2mo ago −6.49%α −6.57% · $44.96
- T+20 · 7w ago −9.21%α −9.57% · $43.65
- T+53 · todayOpen
- T+60 · in 8d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A federal magistrate judge barred the plaintiffs' economic expert in a single product-liability case against Boston Scientific over its Obtryx pelvic mesh sling, due to the plaintiffs' repeated failure over two years to produce tax returns needed for the defense's rebuttal. This is a procedural win for BSX in an individual case, but the ruling does not resolve liability or set precedent for the broader pelvic mesh litigation.
Court Ruling Details
Key Facts
- Court barred plaintiffs' economic expert Andrew Verzilli under Rule 37(c)(1) for failure to produce tax returns despite multiple court orders and extensions over two years.
- The case is an individual product-liability action (not a class action or MDL) involving the Obtryx Transobturator Mid-Urethral Sling System.
- No monetary damages were awarded; the ruling only limits plaintiffs' ability to present expert testimony on lost wages.
- Boston Scientific is a $70B market cap company; this single case is immaterial to its financials.
Financial Impact
No monetary damages awarded; ruling limits plaintiffs' ability to prove lost wages in this individual case.
Risk Factors
- Other pelvic mesh cases against BSX may proceed with expert testimony on economic damages.
- Plaintiffs could appeal the exclusion ruling, though success is unlikely given the extensive record of non-compliance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-85673bd292-BSX |
Track record
22 reports on BSX
4 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +9.24% at T+20 after the Aug 26, 2026 report. 7 of 9 went positive at some point.
Filters
- Oct 28, 202619d ago 8-K Bearish 6/10 No price data
- Oct 28, 202619d ago Press Release Bearish 5/10 Entry $42.43 Now $43.69 −2.97% settles Nov 25
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $45.69 Now $43.69 +4.38% settles Nov 20
- Oct 7, 20265w ago 8-K Mixed 6/10 Entry $41.58 to $45.82 Now $43.69 +5.07% ▲ +10.20% +11.54% vs SPY
- Sep 23, 20267w ago 8-K Bearish 5/10 Entry $44.62 to $44.51 Now $43.69 +2.08% ▲ +0.25% +0.93% vs SPY
- Aug 31, 202611w ago Court Ruling Neutral 2/10 Viewing Entry $48.08 to $43.65 Now $43.69 −9.13% ▼ −9.21% −9.57% vs SPY
- Aug 26, 202611w ago 8-K Bearish 6/10 Entry $48.17 to $43.72 Now $43.69 +9.30% ▲ +9.24% +10.44% vs SPY
- Aug 22, 202612w ago Institutional Cluster Mixed 6/10 Entry $49.01 to $44.92 Now $43.69 −10.85% ▼ −8.35% −9.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 6/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
- Aug 7, 202614w ago Insider Cluster Mixed 5/10 Entry $50.46 to $44.98 Now $43.69 −13.42% ▼ −10.86% −9.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers